2017 PMF Bacterial Endotoxin Summit: Before and Beyond LER

While “LER” has dominated the BET landscape for a few years, many of us are still concerned with day-to-day testing issues. This year, we look to reinforce principles of BET that might be confusing, look to challenges with new products such as cellular and gene therapies and combination products, and discuss new paradigms on BET related topics.